Bentham Science Logo

Track Your Manuscript:


Current Drug Safety

Volume 16, 3 Issues, 2021
ISSN: 2212-3911 (Online)
ISSN: 1574-8863 (Print)
This journal supports open access

Most Accessed Articles






Efficacy and Cardiovascular Safety of GLP-1 Receptor Analogues

, 2021; 16(2): 197-206.

Anoop Mohamed Iqbal, Nasvin Imamudeen, Amjad Basheer, Sukrita Menon, Gisha Mohan, Tesil Nedumkallel Sani and Nisha Nigil Haroon*


DOI: 10.2174/1574886315999201208212356












Use of Sodium-Glucose Co-Transporter-2-Inhibitors (SGLT2-Is) and Risk of Lower Limb Amputation

, 2021; 16(1): 62-72.

Nikki C.C. Werkman, Johannes T.H. Nielen, Joop P.W. van den Bergh , Niels Ejskjaer, Johan Røikjer, Nicolaas C. Schaper, Bernardette Rossi , Olaf Klungel, Peter Vestergaard, Frank de Vries* and Johanna H.M. Driessen


DOI: 10.2174/1574886315666200805103053



Delirium Secondary to Lamotrigine Toxicity

, 2020; 15(2): 156-159.

Deborah L. Sanchez*, Adam J. Fusick, Steven R. Gunther, Michael J. Hernandez, Gregory A. Sullivan, Maria C. Catalano and Glenn Catalano


DOI: 10.2174/1574886315666200225111057



Editor-in-Chief

Seetal Dodd
School of Medicine
University of Melbourne
Geelong, Melbourne
(Australia)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Safety Journal was launched in 2006. Dr. Seetal Dodd serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog